What type of diseases can monoclonal antibodies target?

Monoclonal antibodies are engineered to target specific antigens present on cells or pathogens, making them versatile tools in the treatment of a wide range of diseases. Their ability to bind precisely to these targets allows them to be utilized in various medical contexts.

They are particularly effective in treating cancers because many tumor cells express unique antigens that can be specifically targeted. In the realm of autoimmune disorders, monoclonal antibodies can inhibit harmful immune responses that mistakenly attack the body’s own cells. This specificity makes them valuable in conditions such as rheumatoid arthritis and multiple sclerosis.

Furthermore, monoclonal antibodies have applications in infectious diseases, providing targeted therapy against specific pathogens. They can also be designed to deliver drugs or toxins directly to disease sites, enhancing treatment efficacy while minimizing side effects.

The broad applicability of monoclonal antibodies clearly indicates their capacity to tackle diverse diseases, which is why the correct choice encompasses various diseases including cancers and autoimmune disorders.